Roche immunoassay B-type natriuretic peptide precursor assay second generation - Taiwan Registration a34db0bb5334685489e9087e1e180dde
Access comprehensive regulatory information for Roche immunoassay B-type natriuretic peptide precursor assay second generation in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a34db0bb5334685489e9087e1e180dde and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Performance (specifications 08836752190 new applicable models) changes: This product uses electrochemiluminescence immunoassay (ECLIA) with cobas e 402 and cobas e 801 immunoassay analyzers to quantitatively detect N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum and plasma in vitro.
A Clinical chemistry and clinical toxicology
A.1150 ๆ กๆญฃๅ;; A.1117 Bๅๅฉๅฐฟ้่ฝ่ฉฆ้ฉ็ณป็ตฑ
import
Dates and Status
Jul 20, 2017
Jul 20, 2027
Roche immunoassay B-type natriuretic peptide precursor assay second generation
ROCHE DIAGNOSTICS GMBH
22165506de2ee178ed749b298fc609c9
2
Roche immunoassay B-type natriuretic peptide precursor assay second generation
ROCHE DIAGNOSTICS GMBH
076771454884a304ece989a8a827d3e6
2